Navigation Links
New Drug That Might Help Congestive Heart Failure Patients

Most patients with congestive heart failure respond to standard treatments, which include diuretics, ACE inhibitors and beta-blockers. However, nearly 30 percent of these patients return to the hospital //within two months, and some of the medications can cause serious side effects such as electrolyte abnormalities and worsening kidney function. Researchers say a new drug Tolvaptan may be more effective than existing medications for treating patients with congestive heart failure.

Patients are usually hospitalized because of fluid retention, which occurs when the body overcompensates for a weak heart. When the heart struggles to beat efficiently, the brain produces a hormone called vasopressin, which constricts blood vessels and causes fluid retention. Researchers studied Tolvaptan -- a drug that targets vasopressin -- to determine if it effectively reduces fluid retention.

More than 300 patients with severe heart failure participated in the study. Researchers divided the participants into four groups and followed them for seven weeks. Patients received either 30 milligrams, 60 milligrams or 90 milligrams of Tolvaptan or a placebo in addition to standard medications. Results of the study showed patients who took Tolvaptan weighed less within 24 hours, indicating a decrease in fluid retention. The mortality rate was also lower for those in the Tolvaptan group. Researchers say there were no changes in worsening heart failure between the groups at 60 days.

Based on the results of the above study researchers conclude saying that they now have an agent that appears promising and safe.
'"/>




Page: 1

Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... ... Viewers who like to educate themselves on current issues and who enjoy gaining ... issues tend to appreciate and love the "Informed" series, hosted by Rob Lowe. ... causes around the world. , Running for charity has become a multi-million ...
(Date:3/24/2017)... Texas (PRWEB) , ... March 24, 2017 , ... ... 2017 the year of enhancements, upgrading their training and leads programs. , In ... University. Reserved for elite sales agents, Performance Partners is designed to teach how ...
(Date:3/24/2017)... ... , ... “Finding Christ Through Social Media: Year One #A365DayJourney ... writer’s path toward true communion with God. “Finding Christ Through Social Media: Year ... of published author Lea Michelle Johnson, a follower of Christ, wife and mother ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... Discovery and Diagnostics, 2017 - 2035" report to their offering. ... The Deep Learning: ... and future outlook of the growing market of deep learning solutions ... deep learning algorithms have emerged as a novel solution to generate ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , ... are provided for the period 2015 through 2022. Also, a six-year historic ...
(Date:3/24/2017)... 2017  Mirabilis Medical, a Seattle ... non-invasive surgery, announced today CE Mark authorization for ... uterine fibroids throughout the European Union.  The company ... the US Food and Drug Administration to begin ... the United States.  The Mirabilis System combines high-speed ...
Breaking Medicine Technology: